Cheng‐Hsuan Tsai
Cheng‐Hsuan Tsai publishes mostly in Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Hormonal Regulation and Hypertension, Adrenal and Paraganglionic Tumors and Renin-Angiotensin System Studies.
- World rank
- #1,267,444 of 7,710,434 ranked researchers
- Rank in Taiwan
- #6,563 of 57,035
- Works
- 112
- Citations
- 928
- Citations per work
- 8.3
What does Cheng‐Hsuan Tsai research?
Cheng‐Hsuan Tsai's work is mostly in Medicine (73%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences8272.8%
- Medicine8272.8%
- Everything else2320.2%
- Life Sciences87.0%
- 1Endocrinology, Diabetes and Metabolism23% of their works
- 2Cardiology and Cardiovascular Medicine21% of their works
- 3Surgery16% of their works
- 4Molecular Biology7% of their works
- 5Pulmonary and Respiratory Medicine7% of their works
- 6Nephrology5% of their works
Research topics
- Hormonal Regulation and Hypertension
- Adrenal and Paraganglionic Tumors
- Renin-Angiotensin System Studies
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Blood Pressure and Hypertension Studies
- Adrenal Hormones and Disorders
- Parathyroid Disorders and Treatments
- Cardiovascular, Neuropeptides, and Oxidative Stress Research
Which keywords describe Cheng‐Hsuan Tsai's research?
The keywords of their largest research topics: Hypertension, Cardiovascular Events, Aldosterone, Primary Aldosteronism, Cardiovascular Disease, Paraganglioma, Pheochromocytoma and Angiotensin.
- Vasoconstriction
- FGF23
- Adrenal Insufficiency
- Cardiac Amyloidosis
- Antihypertensive Drugs
- Angiotensin
- Paraganglioma
- Primary Aldosteronism
- Cardiovascular Events
- Hypertension
- Aldosterone
- Cardiovascular Disease
- Pheochromocytoma
- Renin
- Blood Pressure
- Transthyretin
- Corticosteroid Therapy
- Urotensin II
- phosphate
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Hypertension1114 topics
- Cardiovascular Events762 topics
- Aldosterone571 topic
- Primary Aldosteronism571 topic
- Cardiovascular Disease543 topics
- Paraganglioma261 topic
- Pheochromocytoma261 topic
- Angiotensin231 topic
- Renin231 topic
- Antihypertensive Drugs191 topic
- Blood Pressure191 topic
- Cardiac Amyloidosis191 topic
- Transthyretin191 topic
- Adrenal Insufficiency141 topic
- Corticosteroid Therapy141 topic
- FGF23121 topic
- Urotensin II121 topic
- Vasoconstriction121 topic
- phosphate121 topic
Where does Cheng‐Hsuan Tsai work?
Cheng‐Hsuan Tsai's main affiliation in the publication record is National Taiwan University Hospital, Taiwan.
How many publications and citations does Cheng‐Hsuan Tsai have?
OpenAlex counts 112 works and 928 citations for Cheng‐Hsuan Tsai, an h-index of 16, ranking #1,267,444 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Cheng‐Hsuan Tsai. Posts are plain text and can be reported.